MPI STANNOUS DIPHOSPHONATE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Apr 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MPI Stannous Diphosphonate is an injectable diagnostic radiopharmaceutical approved by GE HealthCare in 1977. The product is a stannous diphosphonate complex used as an imaging agent in nuclear medicine. It functions as a bone imaging tracer, localizing to areas of increased bone metabolism and blood flow.
LOE Approaching
As an aging diagnostic product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely consolidating and focused on operational efficiency rather than growth investments.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on MPI Stannous Diphosphonate offers limited career growth due to zero linked job openings and approaching loss of exclusivity. This role is best suited for professionals seeking experience in mature product management, regulatory compliance, or operational optimization rather than dynamic commercial or clinical development.
Regulatory Affairs SpecialistProduct Manager
Worked on MPI STANNOUS DIPHOSPHONATE at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.